Fei Fah Ultra Strength Electric Medicated Balm Recall: CGMP Deviations
Fei Fah Medical is recalling Ultra Strength Electric Medicated Balm due to CGMP deviations. Check lot numbers and expiration dates for affected units.
Recall notice
CGMP Deviations
What happened, in plain English
Fei Fah Medical Manufacturing Pte. Ltd. is recalling Ultra Strength Electric Medicated Balm containing menthol and methyl salicylate because of Current Good Manufacturing Practice (CGMP) deviations. The recall covers approximately 171,120 units distributed nationwide in the U.S. The specific nature of the manufacturing deviations and the resulting health risks are not detailed in the provided record. Read more at govinfonow.com/recall/2084705-fei-fah-medical-manufacturing-pte-ltd-recalls-ultra-strentgh-electric.
Source Summary by GovInfoNow · govinfonow.com/recall/2084705-fei-fah-medical-manufacturing-pte-ltd-recalls-ultra-strentgh-electric · Published November 10, 2026 · Updated November 11, 2026 · FDA enforcement record: FDA #D-0104-2027
Cite this page
“Fei Fah Ultra Strength Electric Medicated Balm Recall: CGMP Deviations.” GovInfoNow, updated November 11, 2026. https://govinfonow.com/recall/2084705-fei-fah-medical-manufacturing-pte-ltd-recalls-ultra-strentgh-electric. Based on FDA recall #D-0104-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0104-2027%22&limit=1).
Why it’s dangerous
The recall is due to deviations from Current Good Manufacturing Practice (CGMP) standards. The record does not specify what these deviations were or how they might affect the product's safety, efficacy, or contamination status.
Who’s affected
Consumers in the United States who purchased Ultra Strength Electric Medicated Balm from various retailers nationwide between the production dates and expiration dates listed. Individuals using topical pain relief balms are the primary group potentially affected.
How to tell if you have this one
Look for 'Ultra Strength Electric Medicated Balm' packaged in 2.45 oz (70g) or 10g containers. Check the label for NDC numbers 63299-001-01 or 63299-001-02, manufactured by Fei Fah Medical Mfg Pte Ltd in Singapore. Affected lots include 23FEBU7001-019 (Exp Oct 2028), 24FEBU7001-020 (Exp Nov 2029), 23FEBU1001-9 (Exp Oct 2028), and 24FEBU1001-004 (Exp Nov 2029).
- Brand
Fei Fah Medical- Category
Drug
What to do — step by step
Check Your Product
Verify if your balm matches the brand, NDC numbers, lot codes, and expiration dates listed in the recall record.
Contact Distributor for Instructions
Since no specific remedy is stated, contact the U.S. distributor, Solistice Medicine Company, at 215 West Ann Street, Los Angeles, CA 90012, for further guidance on what to do with the product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the U.S” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 12 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0104-2027 (October 23, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0104-2027 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on November 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.